News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
667,516 Results
Type
Article (55232)
Company Profile (654)
Press Release (611630)
Multimedia
Podcasts (83)
Webinars (7)
Section
Business (184037)
Career Advice (2560)
Deals (33459)
Drug Delivery (98)
Drug Development (74918)
Employer Resources (133)
FDA (15611)
Job Trends (15675)
News (316161)
Policy (30942)
Tag
2024 BioCapital Digital (20)
2024 BioForest Digital (16)
2024 BioForest Standard (1)
2024 BioMidwest Digital (14)
2024 BioMidwest Standard (2)
2024 Bio NC Digital (19)
2024 Bio NC Standard (1)
2024 Biotech Bay Standard (11)
2024 Biotech Beach Digital (14)
2024 Biotech Beach Standard (5)
2024 Genetown Digital (10)
2024 Genetown Standard (7)
2024 Lone Star Bio Digital (17)
2024 Pharm Country Digital (13)
2024 Pharm Country Standard (5)
2025 BioForest Digital (13)
2025 Lone Star Bio Digital (14)
2026 BioCapital Elite (1)
2026 BioCapital Standard (1)
2026 BioMidwest Elite (2)
2026 Bio NC Standard (1)
2026 Biotech Bay Elite (1)
2026 Biotech Beach Elite (2)
2026 Genetown Elite (3)
2026 Genetown Standard (1)
2026 Pharm Country Elite (1)
2026 Pharm Country Premier (1)
2026 Pharm Country Standard (2)
Academia (2795)
Academic (1)
Accelerated approval (5)
Adcomms (16)
Allergies (88)
Alliances (44847)
ALS (98)
Alzheimer's disease (1402)
Antibody-drug conjugate (ADC) (125)
Approvals (15624)
Artificial intelligence (256)
Autoimmune disease (26)
Automation (15)
Bankruptcy (286)
Best Places to Work (12348)
BIOSECURE Act (18)
Biosimilars (91)
Biotechnology (453)
Bladder cancer (79)
Brain cancer (27)
Breast cancer (282)
Cancer (2255)
Cardiovascular disease (176)
Career advice (2118)
Career pathing (29)
CAR-T (151)
Cell therapy (430)
Cervical cancer (21)
Clinical research (60814)
Collaboration (856)
Compensation (534)
Complete response letters (19)
COVID-19 (2436)
CRISPR (42)
C-suite (248)
Cystic fibrosis (104)
Data (2180)
Decentralized trials (1)
Denatured (9)
Depression (48)
Diabetes (255)
Diagnostics (6650)
Digital health (19)
Diversity (4)
Diversity, equity & inclusion (26)
Drug discovery (124)
Drug pricing (98)
Drug shortages (22)
Duchenne muscular dystrophy (93)
Earnings (72497)
Editorial (39)
Employer branding (20)
Employer resources (115)
Events (110679)
Executive appointments (762)
FDA (16884)
Featured Employer (39)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (2)
Frontotemporal dementia (7)
Funding (780)
Gene editing (105)
Generative AI (20)
Gene therapy (300)
GLP-1 (669)
Government (4285)
Grass and pollen (6)
Guidances (51)
Healthcare (20277)
Huntington's disease (18)
IgA nephropathy (26)
Immunology and inflammation (119)
Indications (28)
Infectious disease (2578)
Inflammatory bowel disease (144)
Inflation Reduction Act (8)
Influenza (52)
Intellectual property (96)
Interviews (436)
IPO (16704)
IRA (43)
Job creations (3850)
Job search strategy (1846)
Kidney cancer (10)
Labor market (30)
Layoffs (441)
Leadership (16)
Legal (6879)
Liver cancer (74)
Lung cancer (313)
Lymphoma (148)
Machine learning (6)
Management (49)
Manufacturing (310)
MASH (62)
Medical device (14096)
Medtech (14100)
Mergers & acquisitions (17374)
Metabolic disorders (639)
Multiple sclerosis (82)
NASH (21)
Neurodegenerative disease (87)
Neuropsychiatric disorders (27)
Neuroscience (1946)
NextGen: Class of 2025 (7311)
Non-profit (4947)
Northern California (2676)
Now hiring (23)
Obesity (326)
Opinion (244)
Ovarian cancer (73)
Pain (94)
Pancreatic cancer (82)
Parkinson's disease (148)
Partnered (18)
Patents (230)
Patient recruitment (109)
Peanut (49)
People (54996)
Pharmaceutical (132)
Pharmacy benefit managers (16)
Phase I (18828)
Phase II (26414)
Phase III (20590)
Pipeline (1148)
Policy (138)
Postmarket research (2502)
Preclinical (8175)
Press Release (68)
Prostate cancer (103)
Psychedelics (32)
Radiopharmaceuticals (263)
Rare diseases (377)
Real estate (6313)
Recruiting (57)
Regulatory (21891)
Reports (33)
Research institute (2527)
Resumes & cover letters (414)
Rett syndrome (4)
RNA editing (3)
RSV (38)
Schizophrenia (71)
Series A (137)
Series B (90)
Service/supplier (25)
Sickle cell disease (52)
Southern California (2316)
Special edition (16)
Spinal muscular atrophy (135)
Sponsored (24)
Startups (3441)
State (2)
Stomach cancer (10)
Supply chain (71)
Tariffs (35)
The Weekly (72)
United States (23771)
Vaccines (636)
Venture capitalists (38)
Weight loss (204)
Women's health (24)
Worklife (12)
Date
Today (198)
Last 7 days (791)
Last 30 days (2576)
Last 365 days (34361)
2025 (10594)
2024 (36597)
2023 (41380)
2022 (50565)
2021 (55679)
2020 (55831)
2019 (49791)
2018 (37164)
2017 (31596)
2016 (30271)
2015 (35626)
2014 (28414)
2013 (28117)
2012 (24418)
2011 (24736)
2010 (23263)
Location
Africa (844)
Alabama (56)
Alaska (6)
Arizona (172)
Arkansas (14)
Asia (39196)
Australia (7035)
California (6193)
Canada (1976)
China (532)
Colorado (271)
Connecticut (295)
Delaware (149)
Europe (89908)
Florida (907)
Georgia (214)
Hawaii (1)
Idaho (60)
Illinois (558)
India (27)
Indiana (324)
Iowa (11)
Japan (161)
Kansas (102)
Kentucky (27)
Louisiana (14)
Maine (70)
Maryland (934)
Massachusetts (4787)
Michigan (234)
Minnesota (413)
Mississippi (2)
Missouri (92)
Montana (28)
Nebraska (25)
Nevada (64)
New Hampshire (68)
New Jersey (1762)
New Mexico (27)
New York (1761)
North Carolina (1104)
North Dakota (8)
Northern California (2676)
Ohio (212)
Oklahoma (15)
Oregon (48)
Pennsylvania (1378)
Puerto Rico (12)
Rhode Island (35)
South America (1164)
South Carolina (23)
South Dakota (1)
Southern California (2316)
Tennessee (103)
Texas (914)
Utah (186)
Virginia (166)
Washington D.C. (63)
Washington State (595)
West Virginia (3)
Wisconsin (66)
667,516 Results for "sanofi aventis new jersey".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
New Jersey’s Life Sciences Scene Continues Expanding Beyond Big Pharma
Known as the home of big-name companies including Johnson & Johnson, New Jersey has become a destination for more and more small and midsize life sciences businesses. Choose New Jersey, Grace Therapeutics and Onyx Equities executives discuss the state’s life sciences scene.
April 10, 2025
·
6 min read
·
Angela Gabriel
Job Trends
8 Companies Hiring in New Jersey
Looking for a biopharma job in New Jersey? Check out the
BioSpace
list of eight companies hiring life sciences professionals like you.
January 23, 2025
·
2 min read
·
Angela Gabriel
Earnings
Sanofi Earnings Driven by Dupixent, New RSV Vaccine as Hunt for Deals Continues
Sanofi’s jump in earnings comes with an increased emphasis on R&D and vaccines, plus an eye cast toward M&A to shore up its pipeline.
January 30, 2025
·
2 min read
·
Dan Samorodnitsky
Layoffs
Eisai Will Trim About 7% of US Workforce, Including New Jersey Employees
Eisai’s cuts will affect 121 employees across the Japanese company’s U.S. operations, including 57 people at its American headquarters in Nutley, New Jersey. A company spokesperson said the pharma remains fully committed to the U.S. market.
February 28, 2025
·
1 min read
·
Angela Gabriel
FDA
FDA Action Alert: Regeneron, Sanofi and Abeona
Lined up for the FDA in the coming weeks are a cell-based gene therapy for a rare skin disease and two product expansions for Regeneron, one with partner Sanofi.
April 14, 2025
·
3 min read
·
Tristan Manalac
Clinical research
Sanofi’s $1.4B Kymab Bet Falters as Asthma Drug Stumbles in Phase II
Analysts at Leerink agreed with Sanofi that, despite falling short of statistical significance in the Phase II TIDE-Asthma trial, amlitelimab warrants further development in this indication.
April 16, 2025
·
2 min read
·
Tristan Manalac
Press Releases
Press Release: Sanofi’s respiratory pipeline advances with new data in asthma and plans for new clinical studies in COPD
April 15, 2025
·
10 min read
Immunology and inflammation
Following Rejection, FDA Okays Sanofi/Regeneron’s Dupixent for Chronic Hives
Dupixent, which was rejected by the FDA for chronic spontaneous urticaria in October 2023, is now approved as the first new targeted therapy for the indication in more than 10 years.
April 21, 2025
·
2 min read
·
Tristan Manalac
I&I
Sanofi Commits up to $1.9B for Dren Bio’s Bispecific Antibody for Autoimmune Disease
The deal is the latest in a series of Sanofi investments in its immunology portfolio. According to Sanfoi, DR-0201 can achieve deep B cell depletion, giving it the potential to reset the immune system.
March 20, 2025
·
2 min read
·
Tristan Manalac
Legal
Regeneron Sues Sanofi, Alleging Stonewalling in Dupixent Pact
According to the lawsuit, Sanofi has failed to provide partner Regeneron adequate information regarding the sales of Dupixent—including agreements with payers and pharmacy benefit managers that determine pricing and rebates for the drug.
February 7, 2025
·
2 min read
·
Tristan Manalac
1 of 66,752
Next
